Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Outlook Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get OTLK alerts

About Terry Dagnon

Terry Dagnon is recorded as COO at Outlook Therapeutics, Inc. (OTLK). The newest filing on record that lists Terry Dagnon as COO at Outlook Therapeutics, Inc. (OTLK) is dated February 22, 2021. The proxy statement of Outlook Therapeutics, Inc. reports total compensation of $1,433,955 for Terry Dagnon in fiscal 2022, including a base salary of $353,077. Disclosed compensation is on record for 5 fiscal years. Outlook Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Outlook Therapeutics, Inc. includes Robert C. Jahr (CEO and Board Member), Robert Charles Jahr (CEO and Board Member), Faisal G. Sukhtian (Chairman) and 7 others.

Affiliation history

Company network

Leadership on record at Outlook Therapeutics, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2022 Outlook Therapeutics, Inc. (OTLK) $353,077 $1,433,955
2021 Outlook Therapeutics, Inc. (OTLK) — $300,000
2020 Outlook Therapeutics, Inc. (OTLK) — $159,677
2019 Outlook Therapeutics, Inc. (OTLK) — —
2018 Outlook Therapeutics, Inc. (OTLK) — —

Recent activity

No call appearances or filed executive changes recorded yet.